>> Continued From the Previous Page <<
U.S. District Judge Mark Pittman took a strong stance against the FDA’s approach. Rejecting the agency’s proposed timeline, Judge Pittman ruled in January 2022 that the FDA must release 55,000 pages per month. This expedited schedule aimed to ensure full transparency and public access to the documents by September 2022.
In his latest ruling, Judge Pittman doubled down on the importance of transparency, stating:
“The liberties of a people never were, nor ever will be, secure, when the transactions of their rulers may be concealed from them.” He continued, “The Covid-19 pandemic is long passed and so has any legitimate reason for concealing from the American people the information relied upon by the government in approving the Pfizer Vaccine.”
Despite the FDA’s compliance in releasing over a million pages so far, the plaintiffs argue that critical information remains undisclosed. Aaron Siri, the attorney representing PHMPT, criticized the FDA for withholding essential documents. Siri remarked:
“The FDA clearly lacks confidence in the review that it conducted to license Pfizer’s COVID-19 vaccine because it is doing everything possible to prevent independent scientists from conducting an independent review.”
He added, “The FDA was hiding from the court and the plaintiff one million pages of clinical trial documents from the COVID-19 vaccine clinical trials.”
This decision is a major win for advocates of government accountability. As the pandemic fades into history, the ruling underscores the necessity of examining the decision-making processes behind emergency authorizations. Public access to these documents may illuminate previously hidden aspects of the vaccine’s approval process, potentially restoring or eroding public trust in health institutions.
Gold at $2,600… But This Stock Gives You More for Under $20
The FDA’s attempt to delay transparency sparked widespread backlash, drawing criticism from lawmakers, scientists, and concerned citizens alike. Many see this court-ordered disclosure as a pivotal step in holding the government and pharmaceutical companies accountable.
By June 30, 2025, the remaining documents must be disclosed. Until then, PHMPT and other transparency advocates will continue to scrutinize the released files, searching for answers that could reshape public perceptions of the vaccine rollout.
This ruling highlights the ongoing debate between government secrecy and the public’s right to know. With more revelations on the horizon, the coming months could unveil significant insights into one of the most controversial public health decisions in recent history.
